Onyx Biotec Share price

ONYX

Healthcare Small Cap

35

2.75 (8.53%)

Last updated on 23 Apr, 2026 | 13:07 IST

BUYSELL

Today's High

35.50

Today's Low

33.80

52 Week Low

28.10

52 Week High

58.95

Free Demat with Zero AMC*

Onyx Biotec Chart

ChartIQ

TradingView

Onyx Biotec Share Key Metrics

Volume

12000.00

Market Cap

58.48 CR

LTQ@LTP

2000@35.00

ATP

34.48 Var Margin

53.5 %

Circuit Range

25.8-38.7

Delivery %

100 %

Value

4.14 L

ASM/GSM

No

Market Lot

2000

Summary

Onyx Biotec share price stands at ₹35 at 23 Apr, 2026 | 13:07. The stock Onyx Biotec intraday movement has stayed between ₹33.80 and ₹35.50, while on a 52-week basis it has fluctuated from ₹28.10 to ₹58.95.

In terms of trading activity, Onyx Biotec has recorded a volume of 12000 shares. The Onyx Biotec has a market cap of ₹18132200. The stock’s Average Traded Price (ATP) stands at ₹3448, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2000, 3500.

The Onyx Biotec operates within a circuit range of ₹25.8-38.7 – ₹25.8-38.7, with a Value of ₹4.14 L. The Delivery Percentage for the day is 100%. Additionally, Onyx Biotec currently falls under the No framework, and trades with a market lot size of 2000.

Onyx Biotec Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

63.84

Sector P/B

3.48

Sec. Div. Yield

0.57

Onyx Biotec Resistance and Support

Pivot 32.25

Resistance

First Resistance

32.25

Second Resistance

32.25

Third Resistance

32.25

Support

First Support

32.25

Second Support

32.25

Third Support

32.25

Onyx Biotec Shareholding Pattern

2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

65.1%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.07%

Domestic Institutional Investors

2.39%

Retail

31.44%

Others

0%

Total Promoters

MAR '26

65.1%

Onyx Biotec Corporate Actions

Date	Agenda
2025-11-13	Quarterly Results
2025-05-28	Audited Results

Onyx Biotec News

Onyx Biotec Limited (ONYX)

Onyx Biotec responded to an NSE query by submitting the auditor's signed certificate for the utilization of IPO proceeds for the half year ended September 30, 2025. The company raised ₹2538.02 lakhs, with no deviation from the stated IPO objects.

Apr 22 2026 11:04:00

Onyx Biotec Limited (ONYX)

Onyx Biotec Ltd. confirmed non-applicability of SEBI Corporate Governance provisions for the quarter ended March 31, 2026. This exemption is due to its listing on NSE EMERGE and paid-up equity not exceeding ₹10 crore and net worth not exceeding ₹25 crore.

Apr 07 2026 16:04:00

Onyx Biotec Limited (ONYX)

Onyx Biotec's Promoters and Promoter Group declared that no encumbrance was created on company shares for the financial year ended March 31, 2026. This confirms stability in promoter holdings, which is positive for investor confidence.

Apr 07 2026 16:04:00

Onyx Biotec Limited (ONYX)

Onyx Biotec appointed M/s. Kishore & Kishore, Chartered Accountants, as Internal Auditor for FY2025-26. This appointment was approved by the Board based on the Audit Committee's recommendation.

Mar 26 2026 16:03:00

NSE : 27136

BSE : 0

ISIN : INE0WVU01018

Our Company was incorporated on May 13 2005 as a private limited company as ‘Onyx Biotec Private Limited’ under the Companies Act 1956 pursuant to a certificate of incorporation dated May 13 2005 issued by the Registrar of Companies Punjab H.P. & Chandigarh. Further our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in its meeting held on May 1 2024 and by the Shareholders in an Extraordinary General Meeting held on May 27 2024 and consequently the name of our Company was changed to ‘Onyx Biotec Limited’ and a fresh certificate of incorporation dated July 23 2024 was issued by the Registrar of Companies Central Processing Centre. The corporate identification number of our Company is U24230HP2005PLC028403.Major Events and Milestones:2010-Our Company commenced commercial production at our Unit I with two line of Form Fill and Seal setup with capacity of 2 lacs units per day2017-Capacity expansion at our Unit I from 130 million unit per annum to 230 million units per annum-Our Company received a certificate for Good Manufacturing Practice from Deputy Drugs Controller cum Licensing Authority Health & Family2023-Our Company commenced commercial production at our Unit II

Name	Position
Sanjay Jain	Managing Director
Naresh Kumar	Whole Time Director

Onyx Biotec Similar Stocks

Onyx Biotec FAQs

The Buying Price of Onyx Biotec share is 35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Onyx Biotec stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Onyx Biotec, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Onyx Biotec shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Onyx Biotec shares is 0. Useful to assess the stock's value relative to its book value.

To assess Onyx Biotec’s valuation compare Sector P/E, P/B which are 63.84 & 3.48 with sector averages, along with growth rates and financial metrics.

The Market Cap of Onyx Biotec is 58.48 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Onyx Biotec share price is 58.95 & 28.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Onyx Biotec belongs to the Healthcare sector.